Day-long subcutaneous infusion of exenatide lowers glycemia in patients with type 2 diabetes. - Taylor,K.; Kim,D.; Nielsen,LL.; Aisporna,M.; Baron,AD.; Fineman,MS. (Horm Metab Res, 2005)